The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway

Ciclopirox olamine (CPX), an off-patent antifungal agent used to treat mycoses of skin and nails, has recently been demonstrated to be a potential anticancer agent. However, the underlying mechanism is not well understood. Here for the first time we show that CPX inhibited lymphangiogenesis in an in...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yan, Zhou, Hongyu, Liu, Lei, Shen, Tao, Chen, Wenxing, Xu, Baoshan, Han, Xiuzhen, Zhang, Fangfang, Scott, Rona S., Alexander, J. Steven, Alam, Antoine, Huang, Shile
Formato: Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088775/
https://www.ncbi.nlm.nih.gov/pubmed/21217783
http://dx.doi.org/10.1038/onc.2010.590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088775/
https://www.ncbi.nlm.nih.gov/pubmed/21217783
http://dx.doi.org/10.1038/onc.2010.590

Ejemplares similares